Skip to main content
OpenTrials

Clinical trial condition

Kidney Diseases

Explore clinical trials studying Kidney Diseases. Study availability and eligibility vary by location and protocol.

8,798 public trials 1,412 recruiting studies
Refine in advanced search Browse all conditions

Kidney Diseases trial results

Active, Not Recruiting

Treatment Pause Versus Treatment Continuation in IMDC Good or Intermediate Risk With Only One Adverse Prognostic Factor in mRCC Patients With an Objective Response at 12 Months of Treatment With PD1/ PDL1 ICIs + VEGFR-Tyrosine Kinase Inhibitors

NCT05219318

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • CH de la Cote Basque - Service d'Oncologie Bayonne, France
  • CHU de Bordeaux - Service d'Oncologie Bordeaux, France
  • Centre François Baclesse - Service d'Oncologie Caen, France
  • Centre Jean Perrin - Service d'Oncologie Clermont-Ferrand, France
View all 26 locations
View Trial Details
Active, Not Recruiting

DePTH: De-emphasize PTH

NCT06288451

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +27 more
Locations
  • University of Washington Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

NCT05704985

Conditions
Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +42 more
Locations
  • City of Hope Duarte, California, United States
  • Northwell Health Manhasset, New York, United States
  • OU Health Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Obinutuzumab in Primary MN

NCT05050214

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • ASST HPG23 - Unità di Nefrologia Bergamo, BG, Italy
  • Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò" Ranica, BG, Italy
View Trial Details

Related conditions